United States · FDA National Drug Code directory
Naproxen Sodium HEADACHE PAIN
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 58602-735_b14dd7e8-b43c-4d9e-9609-13d9f30a74c4
- Product NDC
- 58602-735
- Form
- TABLET, FILM COATED
- Composition / generic term
- Naproxen Sodium
- Labeler
- Aurohealth LLC
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20210714
- Source listing expiry
- 20261231
Source-listed ingredients
- NAPROXEN SODIUM — 220 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 1 BOTTLE in 1 CARTON (58602-735-07) / 24 TABLET, FILM COATED in 1 BOTTLE · 58602-735-07
- 1 BOTTLE in 1 CARTON (58602-735-19) / 90 TABLET, FILM COATED in 1 BOTTLE · 58602-735-19
- 1 BOTTLE in 1 CARTON (58602-735-21) / 100 TABLET, FILM COATED in 1 BOTTLE · 58602-735-21
- 1 BOTTLE in 1 CARTON (58602-735-29) / 150 TABLET, FILM COATED in 1 BOTTLE · 58602-735-29
- 1 BOTTLE in 1 CARTON (58602-735-38) / 300 TABLET, FILM COATED in 1 BOTTLE · 58602-735-38
- 1 BOTTLE in 1 CARTON (58602-735-40) / 500 TABLET, FILM COATED in 1 BOTTLE · 58602-735-40
- 1 BOTTLE in 1 CARTON (58602-735-78) / 50 TABLET, FILM COATED in 1 BOTTLE · 58602-735-78
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →